ACME Laboratories (DHA:ACMELAB) Long-Term Capital Lease Obligation : BDT49 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories Long-Term Capital Lease Obligation?

ACME Laboratories's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was BDT49 Mil.

ACME Laboratories's quarterly Long-Term Capital Lease Obligation declined from Jun. 2023 (BDT62 Mil) to Sep. 2023 (BDT58 Mil) and declined from Sep. 2023 (BDT58 Mil) to Mar. 2024 (BDT49 Mil).

ACME Laboratories's annual Long-Term Capital Lease Obligation increased from Jun. 2021 (BDT63 Mil) to Jun. 2022 (BDT73 Mil) but then declined from Jun. 2022 (BDT73 Mil) to Jun. 2023 (BDT62 Mil).

ACME Laboratories Long-Term Capital Lease Obligation Historical Data

The historical data trend for ACME Laboratories's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories Long-Term Capital Lease Obligation Chart

ACME Laboratories Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

66.78

62.89

73.20

62.29

ACME Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															71.95	66.72	62.29	58.07	49.48

ACME Laboratories (DHA:ACMELAB) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

ACME Laboratories Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

ACME Laboratories (DHA:ACMELAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207

Website

https://www.acmeglobal.com

ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.

ACME Laboratories (DHA:ACMELAB) Headlines

No Headlines